| γ-Secretase directly sheds the survival receptor BCMA from plasma cells SA Laurent, FS Hoffmann, PH Kuhn, Q Cheng, Y Chu, ... Nature communications 6 (1), 7333, 2015 | 330 | 2015 |
| Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis M Spadaro, LA Gerdes, M Krumbholz, B Ertl-Wagner, FS Thaler, E Schuh, ... Neurology: Neuroimmunology & Neuroinflammation 3 (5), e257, 2016 | 215 | 2016 |
| Features of human CD3+ CD20+ T cells E Schuh, K Berer, M Mulazzani, K Feil, I Meinl, H Lahm, M Krane, ... The Journal of Immunology 197 (4), 1111-1117, 2016 | 191 | 2016 |
| Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein M Spadaro, S Winklmeier, E Beltrán, C Macrini, R Höftberger, E Schuh, ... Annals of neurology 84 (2), 315-328, 2018 | 171 | 2018 |
| Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration J Havla, T Kümpfel, R Schinner, M Spadaro, E Schuh, E Meinl, R Hohlfeld, ... Journal of neurology 264, 139-151, 2017 | 91 | 2017 |
| Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations E Schuh, P Lohse, B Ertl-Wagner, M Witt, M Krumbholz, M Frankenberger, ... Neuroimmunology & Neuroinflammation 2 (4), e109, 2015 | 55 | 2015 |
| The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration JT Jackson, E Mulazzani, SL Nutt, SL Masters Journal of Biological Chemistry 297 (2), 2021 | 53 | 2021 |
| Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL E Schuh, B Ertl-Wagner, P Lohse, W Wolf, JF Mann, MA Lee-Kirsch, ... Neuroimmunology & Neuroinflammation 2 (1), e55, 2014 | 43 | 2014 |
| Human plasmacytoid dendritic cells display and shed B cell maturation antigen upon TLR engagement E Schuh, A Musumeci, FS Thaler, S Laurent, JW Ellwart, R Hohlfeld, ... The Journal of Immunology 198 (8), 3081-3088, 2017 | 41 | 2017 |
| PET imaging of astrogliosis and tau facilitates diagnosis of Parkinsonian syndromes S Schönecker, M Brendel, C Palleis, L Beyer, GU Höglinger, E Schuh, ... Frontiers in aging neuroscience 11, 249, 2019 | 32 | 2019 |
| APRIL and BAFF: novel biomarkers for central nervous system lymphoma M Mulazzani, M Huber, S Borchard, S Langer, B Angele, E Schuh, E Meinl, ... Journal of hematology & oncology 12, 1-14, 2019 | 27 | 2019 |
| Abundant glutamic acid decarboxylase (GAD)‐reactive B cells in gad‐antibody–associated neurological disorders FS Thaler, AL Thaller, M Biljecki, E Schuh, S Winklmeier, CF Mahler, ... Annals of neurology 85 (3), 448-454, 2019 | 26 | 2019 |
| MCC950 blocks enhanced interleukin-1β production in patients with NLRP3 low penetrance variants E Schuh, CJ Groß, D Wagner, M Schlüter, O Groß, T Kümpfel Clinical Immunology 203, 45-52, 2019 | 25 | 2019 |
| Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study T Wolf A Lagrèze, Sebastian Küchlin, Gabriele Ihorst, Birgit Grotejohann ... Elsevier 20 (12), 991-1000, 2021 | 23* | 2021 |
| Cryopyrin-associated periodic fever syndrome manifesting as Tolosa-Hunt syndrome C Höhne, E Schuh, T Kümpfel, A Straube Cephalalgia 36 (14), 1392-1396, 2016 | 19 | 2016 |
| Magnetic resonance imaging characteristics of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations DM Hedderich, N Lummel, M Deschauer, T Kümpfel, E Schuh, M Patzig, ... Clinical Neuroradiology 30, 229-236, 2020 | 12 | 2020 |
| G-CSF drives autoinflammation in APLAID E Mulazzani, K Kong, JI Aróstegui, AP Ng, N Ranathunga, W Abeysekera, ... Nature immunology 24 (5), 814-826, 2023 | 9 | 2023 |
| Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants E Mulazzani, D Wagner, J Havla, M Schlüter, I Meinl, LA Gerdes, ... Journal of Neuroinflammation 17, 1-13, 2020 | 9 | 2020 |
| A rare case of cerebroretinal vasculopathy caused by a novel Trex 1 mutation E Schuh, P Lohse, T Kuempfel Journal of Neurology 260, S137-S137, 2013 | 2 | 2013 |
| Long-term follow-up of patients with neuromyelitis optica treated with rituximab T Kümpfel, J Havla, E Schuh, H Pellkofer, LA Gerdes, I Meinl, R Hohlfeld MULTIPLE SCLEROSIS JOURNAL 18, 293-293, 2012 | 2 | 2012 |
